Vor Biopharma Inc (VOR)
0.79
-0.01
(-0.77%)
USD |
NASDAQ |
Nov 22, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Shareholders Equity (Quarterly): 72.96M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 72.96M |
| June 30, 2024 | 98.08M |
| March 31, 2024 | 123.04M |
| December 31, 2023 | 150.72M |
| September 30, 2023 | 174.78M |
| June 30, 2023 | 204.45M |
| March 31, 2023 | 230.22M |
| December 31, 2022 | 250.61M |
| September 30, 2022 | 158.73M |
| Date | Value |
|---|---|
| June 30, 2022 | 174.97M |
| March 31, 2022 | 194.45M |
| December 31, 2021 | 216.26M |
| September 30, 2021 | 232.96M |
| June 30, 2021 | 250.11M |
| March 31, 2021 | 267.19M |
| December 31, 2020 | 48.27M |
| September 30, 2020 | 63.19M |
| December 31, 2019 | 7.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.64M
Minimum
Dec 2019
267.19M
Maximum
Mar 2021
162.15M
Average
174.88M
Median
Shareholders Equity (Quarterly) Benchmarks
| Organon & Co | 493.00M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.99M |
| Total Liabilities (Quarterly) | 43.04M |